Supporting Medical Research

Medvet was founded by the Institute of Medical and Veterinary Science (now SA Pathology) to generate profits to direct into medical research. Since 1985 we have returned $32 million to such research projects, and have an ongoing mission to (as an organisation) provide $2 million each year.

We support projects in Australian laboratories and hospitals, advancing knowledge and improving health and well-being for all Australians. Researchers and scientists bring projects to us, and we work with them to usher their ideas from conception through to end-user products or services. Managed by the business unit Adelaide Research Translation, Medvet Science is a website dedicated to discussing current projects and past successes. A brief introduction to each is below.


Firefly (Hypowatch) device

Worn by the patient like a wristwatch, the Hypowatch (pictured right) is a non-invasive way of alerting diabetics to onset of hypoglycaemia


MicroStreak is an automated means of plating microbiology specimens, improving culture performance and laboratory accuracy.

Mesenchymal Stem Cells

This technology draws and isolates stem cells from blood, allowing them to be used to treat tissue damage in the heart, joints or bone.


Nearing human trials, APOMAB is an antibody that targets the proteins in cancer, allowing more precise delivery of treatments.

Down Syndrome

Researchers have identified an earlier and less invasive means of diagnosing Down Syndrome from the mother’s blood.

Schizophrenia Diagnosis

Identifying genetic markers allows doctors to screen patients for neuropsychiatric disorders such as schizophrenia and autism.

Vascular Coatings

By exploring a coating method to apply to vascular implants, researchers look to help reduce implant rejection and thrombosis.

For more information on each of these leading-edge projects, please visit Medvet Science.

Vascular stent

Vascular stent developed by the team at the Royal Adelaide Hospital